购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 Target 筛选
  • Apoptosis
    (1)
  • VEGFR
    (1)
  • c-Met/HGFR
    (3)
筛选
搜索结果
TargetMol产品目录中 "

mgcd 265

"的结果
  • 抑制剂&激动剂
    3
    TargetMol | Inhibitors_Agonists
MGCD-265 analogMGCD-265,Glesatinib analog
T6351875337-44-3
MGCD-265 analog (Glesatinib) 是一种口服生物可利用的多靶点酪氨酸激酶抑制剂,具有抗肿瘤活性,对 c-Met 和 VEGFR2 的 IC50 分别为 29 nM 和 10 nM。
  • ¥ 260
现货
规格
数量
TargetMol | Inhibitor Sale
GlesatinibMGCD265
T15384936694-12-1
Glesatinib is an orally active and potent dual inhibitor of MET/SMO. Glesatinib is also a tyrosine kinase inhibitor. It antagonizes P-glycoprotein mediated multidrug resistance (MDR) in NSCLC.
  • ¥ 11700
6-8周
规格
数量
Glesatinib hydrochlorideMGCD265 hydrochloride
T153831123838-51-6
Glesatinib hydrochloride is an orally active and potent dual inhibitor of MET SMO. Glesatinib hydrochloride is also a tyrosine kinase inhibitor. It antagonizes P-glycoprotein mediated multidrug resistance (MDR) in NSCLC.
  • ¥ 9540
6-8周
规格
数量